Global markets, led by tech stocks, have reached record highs fueled by AI enthusiasm. Investor Paul Tudor Jones likens AI’s current stage to Microsoft’s early dominance and the internet’s commercialization, predicting another year or two of growth. However, he warns of a significant market downturn akin to the dot-com bubble’s aftermath.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026